Selis F - Search Results

1

Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen.

Selis F, Focà G, Sandomenico A, Marra C, Di Mauro C, Saccani Jotti G, Scaramuzza S, Politano A, Sanna R, Ruvo M, Tonon G. Selis F, et al. Int J Mol Sci. 2016 Apr 1;17(4):491. doi: 10.3390/ijms17040491. Int J Mol Sci. 2016. PMID: 27043557 Free PMC article.

2

Generation and testing of engineered multimeric Fabs of trastuzumab.

Selis F, Sandomenico A, Cantile M, Sanna R, Calvanese L, Falcigno L, Dell'Omo P, Esperti A, De Falco S, Focà A, Caporale A, Iaccarino E, Truppo E, Scaramuzza S, Tonon G, Ruvo M. Selis F, et al. Int J Biol Macromol. 2020 Dec 1;164:4516-4531. doi: 10.1016/j.ijbiomac.2020.09.050. Epub 2020 Sep 14. Int J Biol Macromol. 2020. PMID: 32941911

3

Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes.

Selis F, Schrepfer R, Sanna R, Scaramuzza S, Tonon G, Dedoni S, Onali P, Orsini G, Genovese S. Selis F, et al. Results Pharma Sci. 2012 Sep 18;2:58-65. doi: 10.1016/j.rinphs.2012.09.001. eCollection 2012. Results Pharma Sci. 2012. PMID: 25755995 Free PMC article.

4

Ultra-performance liquid chromatography/multiple reaction monitoring mass spectrometry quantification of trastuzumab in human serum by selective monitoring of a specific peptide marker from the antibody complementarity-determining regions.

Russo R, Rega C, Caporale A, Tonon G, Scaramuzza S, Selis F, Ruvo M, Chambery A. Russo R, et al. Among authors: selis f. Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1184-1192. doi: 10.1002/rcm.7898. Rapid Commun Mass Spectrom. 2017. PMID: 28488747

5

The LQSP tetrapeptide is a new highly efficient substrate of microbial transglutaminase for the site-specific derivatization of peptides and proteins.

Caporale A, Selis F, Sandomenico A, Jotti GS, Tonon G, Ruvo M. Caporale A, et al. Among authors: selis f. Biotechnol J. 2015 Jan;10(1):154-61. doi: 10.1002/biot.201400466. Epub 2014 Dec 16. Biotechnol J. 2015. PMID: 25388890

6

A comparative analysis of catalytic activity and stability of microbial transglutaminase in controlled denaturing conditions.

Caporale A, Monti A, Selis F, Sandomenico A, Tonon G, Ruvo M, Doti N. Caporale A, et al. Among authors: selis f. J Biotechnol. 2019 Aug 20;302:48-57. doi: 10.1016/j.jbiotec.2019.06.299. Epub 2019 Jun 20. J Biotechnol. 2019. PMID: 31229602

7

A recent update on the use of microbial transglutaminase for the generation of biotherapeutics.

Doti N, Caporale A, Monti A, Sandomenico A, Selis F, Ruvo M. Doti N, et al. Among authors: selis f. World J Microbiol Biotechnol. 2020 Mar 14;36(4):53. doi: 10.1007/s11274-020-02829-y. World J Microbiol Biotechnol. 2020. PMID: 32172335 Review.

8

Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1.

Sandomenico A, Selis F, Sivaccumar JP, Olimpieri P, Iaccarino E, Cicatiello V, Cantile M, Sanna R, Leonardi A, De Falco S, Ruvo M. Sandomenico A, et al. Among authors: selis f. Biochem Biophys Res Commun. 2024 Jan 29;694:149417. doi: 10.1016/j.bbrc.2023.149417. Epub 2023 Dec 21. Biochem Biophys Res Commun. 2024. PMID: 38150919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page